A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.

NCT02425826 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Parapsoriasis

Interventions

DRUG: Apremilast
DRUG: Placebo
DRUG: Placebo-Apremilast

Sponsor

Amgen